Unique ID issued by UMIN | UMIN000027664 |
---|---|
Receipt number | R000031348 |
Scientific Title | Examination of the usefulness of new dosage forms for external preparation (frothiness sprays) of the heparin similar material agent |
Date of disclosure of the study information | 2017/06/09 |
Last modified on | 2019/03/29 10:03:36 |
Examination of the usefulness of new dosage forms for external preparation (frothiness sprays) of the heparin similar material agent
Usefulness examination of the Form Spray
Examination of the usefulness of new dosage forms for external preparation (frothiness sprays) of the heparin similar material agent
Usefulness examination of the Form Spray
Japan |
dry skin
Dermatology |
Others
NO
Examination of the usefulness of new dosage forms for external preparation (frothiness sprays) on the patient with the skin drying symptom
Others
impression from use
Others
Not applicable
Rate of change of the water content in epidermal stratum corneum of 4 weeks
Usability of the patient
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
YES
NO
Institution is not considered as adjustment factor.
NO
No need to know
1
Prevention
Medicine |
4 weeks, appropriate amount, appropriately
1 | years-old | <= |
75 | years-old | > |
Male and Female
1) The patients who it present a skin drying symptom, and are treated for a heparin similar material agent for external preparation.
2) The patients that an agreement were provided in a document after having explained this study contents.
1) Patients who are treated for an agent for anti-inflammatory external preparation, and they visit a hospital for treatment regularly.
2) Patients with hemorrhagic blood disorder
3) Patient that it are expected that little bleeding causes a serious result.
4) Patients who use a steroid or anti-allergic drug.
5) Patients with a medical history of the serious disease.
6) Patients who have difficulty in patient diary entry.
7) A pregnant woman or the woman who may be pregnant and the woman whom I am nursing. The patient who hopes for the pregnancy during a study period.
8) The patients that the co-investigator judged this study enforcement to be inappropriate.
9) The patients who participate in other clinical trials for the past three months.
40
1st name | |
Middle name | |
Last name | Makoto Kawashima |
Tokyo Woman's Medical University
(Non-Profit Organization Health Institute Research of Skin)
Department of Dermatology
8-1 Kawada-cho, Shinjyuku-ku, Tokyo, Japan
03-3353-8111
kawashima.makoto@twmu.ac.jp
1st name | |
Middle name | |
Last name | Yoshitaka Ogaki |
EBC&M LLC.
Project planning & Development department
CROSS OFFICE MITA 9F 5-29-20, Shiba, Minato-ku, Tokyo, Japan
03-6435-3833
yoshitaka_ogaki@ebc-m.com
Non-Profit Organization Health Institute Research of Skin
Nippon Zoki Pharmaceutical Co.,LTD
Profit organization
NO
2017 | Year | 06 | Month | 09 | Day |
Unpublished
Completed
2017 | Year | 03 | Month | 27 | Day |
2017 | Year | 04 | Month | 04 | Day |
2017 | Year | 04 | Month | 12 | Day |
2017 | Year | 05 | Month | 31 | Day |
2017 | Year | 05 | Month | 31 | Day |
2017 | Year | 06 | Month | 05 | Day |
2017 | Year | 06 | Month | 19 | Day |
2017 | Year | 06 | Month | 06 | Day |
2019 | Year | 03 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031348
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |